Preventing stroke in outback communities

Research Updates
A smart phone app that can detect heart abnormalities in just 30 seconds is being trialled in Aboriginal and Torres Strait Islander communities across Australia.

The game-changing technology, known as the AliveCor/Kardia Heart Monitor for smartphone or iECG, can detect atrial fibrillation (AF), an irregular heart rhythm linked to severe and catastrophic stroke.

The research project, which started in Brewarrina, NSW, will travel to communities including Toomelah, Boggabilla, Mungindi, Moree, Inverell, Geraldton and Alice Springs over the next 12 months, conducting 1500 screenings.

Professor Ben Freedman, Deputy Director of Research and Strategy at the Heart Research Institute and Charles Perkins Centre, says: 

“AF causes of one third of all strokes in Australia – and most are potentially preventable."

“But this requires detection of the abnormal heart rhythm which is often asymptomatic before stroke occurs,” he said.

Using the app, patients places their fingers on connectors on the back of the phone for 30 seconds. The file is then analysed by the app to detect AF. The technology mean patients can get the treatment they need before stroke happens.

The technology will also create the first national snapshot of AF rates in Aboriginal people and aim to improve cardiovascular health literacy in Aboriginal communities.

Currently there are no published studies about the prevalence of AF in people from Aboriginal and Torres Strait Islander backgrounds, despite it being a leading risk factor for ischaemic stroke, a condition affecting one in 25 Aboriginal people.

The new pilot program is run by the Poche Centre for Indigenous Health at the University of Sydney and funded by the National Heart Foundation.

The screening will be accompanied by a public awareness campaign into the causes, prevention, symptoms and treatment of cardiovascular disease. The 35 devices will also remain in the communities after the screening is completed, with dedicated Aboriginal health workers given training on how to use the iECGs in future.


Related news

Crystal ball molecule predicts diabetes before it strikes

HRI researchers have developed a simple test to predict diabetes more than a decade before it strikes, a breakthrough that could help ease the impending diabetes epidemic. The team has uncovered an important molecule found in liver fat that can identify who is most at risk of developing diabetes and other cardio-metabolic disorders like liver disease.  

Read more

New drug hope to target silent killer

An exciting new treatment for very high blood pressure is on the horizon after a world-first discovery by Heart Research Institute scientists, who have uncovered a brain chemical instrumental in triggering hypertension, the so-called silent killer responsible for the deaths of thousands of Australians each year.

The researchers are optimistic the results, published this week in the American Journal of Physiology-Heart and Circulatory Physiology, will ultimately lead to a powerful new treatment that blocks a neurotransmitter and frees patients from the dangers of hypertension. 

Read more

Gout drug mends broken hearts

A drug used to treat arthritis has been found to clear clogged arteries in heart attack survivors, world-first Australian research shows.

The landmark discovery by Associate Professor Sanjay Patel, Leader of the Cell Therapeutics Group, and his team at the HRI paves the way for a cheap, simple and effective treatment regime that could protect thousands of Australian heart patients from future attacks that might kill them or further damage their heart. 

Read more